The Medicine Maker: Oral Alternatives for Injectable IV Medicines
Hong-yu Li, PhD, Department of Pharmacology and the Sam and Ann Barshop Institute for Longevity and Aging Studies, was quoted in this article. Read More
Share This Story
Newsroom health conditions id
190
Community Impact: UT Health study blends tai chi with AI for dementia patient treatment
Wei Liu, PhD, associate professor, Department of Physical Therapy, and research director of Rehabilitation, Integrative and Complementary Health, was quoted in this article, and Lixin Song, PhD, professor and vice dean of research and scholarship, School of Nursing, was mentioned. Read More
Share This Story
Engineering News-Record: $100M Brain Health Hub Rises on Tight Site in San Antonio
Sudha Seshadri, MD, professor and founding director of the Glenn Biggs Institute for Alzheimer’s and Neurogenerative Diseases, and Michael Charlton, PhD, senior vice president of Facilities and Capital Planning and chief facility planning officer, were interviewed for this article. Read More
Share This Story
UT Health San Antonio-led discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments
Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer’s disease. The discovery could reshape how medicines […]
Share This Story
Texas Public Radio: UT Health San Antonio researchers may be able to turn IV drugs into oral treatment for Alzheimer’s
Robert A. Hromas, MD, FACP, dean of the Joe R. and Teresa Lozano Long School of Medicine, was quoted in this article. Read More
Share This Story